Women and girls in Africa are at escalated risk of violence, exploitation, poverty, and HIV infection, due to the Trump administration’s abrupt shuttering of more than 80 percent of the United States Agency for International Development and 70 percentof the agency’s HIV programs, along with deep cuts to the President’s Emergency Plan for AIDS Relief (PEPFAR). The dismantling of U.S. foreign assistance and global health programming perpetuates the reality that HIV has a female face in Africa, reversing recent progress: In 2023, women and girls accounted for 62 percent of all new infections, representing 3,100 new infections every week, down from 5,500 in 2018. These gains are now under distinct threat, with severe health security and economic consequences for the high-burden countries and the United States.
Countries with high HIV prevalence rates must now make tough choices about how to keep vulnerable young women healthy, safe, and economically productive, goals that donors, the private sector, and civil society organizations could help them achieve. Despite constrained domestic and global resources, national systems should be reinforced to provide sustainable, affordable, and accountable services. Otherwise, HIV acquisition among girls and young women, who are more than three times as likely to acquire HIV as their male peers, will be the leading edge of a resurgent epidemic that knows no borders.
The path forward will depend on national governments and their partners strategizing around four central challenges, which will require innovative financing and service delivery, prioritization, and leveraging U.S. and other bilateral and multilateral donors, and private sector capacities: (1) how to promote precision and efficiencies in public and private sector service delivery to address HIV risk for young women; (2) how to facilitate access for adolescent girls and young women to the most effective biomedical prevention products; (3) how prevention services focusing on social, economic, and health factors can be integrated into national platforms; and (4) where the use of advanced modeling and new diagnostic capabilities can help monitor impact and track progress. As Professor Quarraisha Abdool-Karim, a leading HIV researcher in South Africa, explained to me in a recent interview: “We can’t do everything everywhere all at once; we have to choose our battles and prioritize based on data and feasibility and logistics and coverage rates, and build from there.”
Click here to link to the commentary.